Decreased Platelet Reactivity in Blood Anticoagulated with Bivalirudin or Enoxaparin Compared with Unfractionated Heparin: Implications for Coronary Intervention

@article{Aggarwal2002DecreasedPR,
  title={Decreased Platelet Reactivity in Blood Anticoagulated with Bivalirudin or Enoxaparin Compared with Unfractionated Heparin: Implications for Coronary Intervention},
  author={Atul Aggarwal and B. E. Sobel and David J. Schneider},
  journal={Journal of Thrombosis and Thrombolysis},
  year={2002},
  volume={13},
  pages={161-165}
}
Background: Platelet reactivity predicts complications after percutaneous coronary intervention (PCI). Accordingly, agents that suppress platelet reactivity should decrease adverse events after PCI. This study was designed to determine the effects of therapeutic concentrations of unfractionated heparin (UFH), bivalirudin, or enoxaparin alone or in combination with tirofiban on platelet reactivity. Methods: Blood taken from 13 patients with coronary artery disease was exposed to each… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 11 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 21 references

Similar Papers

Loading similar papers…